HPV 28 Genotyping Detection Kit - Taizhou Cowingene Biotech Co., Ltd.|Advanced PCR Technology

The Cowingene HPV 28 Genotyping Detection Kit represents a significant advancement in molecular diagnostics for human papillomavirus (HPV) detection. Developed by Taizhou Cowingene Biotech Co., Ltd., this kit utilizes polymerase chain reaction (PCR) technology to identify 28 high-risk HPV subtypes, offering a reliable solution for early cervical cancer detection and risk stratification.

Product Overview

The Cowingene HPV 28 Genotyping Detection Kit is designed for clinical laboratories and healthcare providers to detect and genotype HPV infections. With the ability to identify 28 high-risk HPV subtypes, this kit provides critical data for patient management and cancer prevention strategies. The product is validated for use with multiple sample types, including cervical swabs, urine, and self-collected vaginal specimens, making it a versatile tool in diverse healthcare settings.

Image: HPV Detection by PCR

Technical Specifications

Parameter	Details
Test Type	Quantitative PCR for HPV Genotyping
HPV Subtypes Detected	16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 55, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83, 6, 11
Sample Types	Cervical swab, Urine, Self-collected vaginal
Sensitivity	≥95% (as validated by clinical trials)
Specificity	≥98% (cross-reactivity minimized)
Processing Time	Less than 4 hours (including DNA extraction)
Storage Conditions	-20°C for reagents; 2-8°C for stabilized samples

Advantages of the Cowingene HPV 28 Kit

The Cowingene HPV 28 Genotyping Detection Kit offers several advantages over traditional HPV detection methods:

• Comprehensive Coverage: Detects 28 high-risk HPV subtypes, including the most prevalent ones like 16 and 18, which are responsible for over 70% of cervical cancer cases.
• High Accuracy: Utilizes advanced PCR technology to ensure high sensitivity and specificity, reducing false positives/negatives.
• Sample Flexibility: Accepts cervical swabs, urine, and self-collected vaginal samples, improving patient compliance and accessibility.
• Efficient Workflow: Streamlined protocols minimize hands-on time, enabling high-throughput testing in clinical laboratories.

Image: Human Papillomavirus PCR

Applications in Clinical Practice

The Cowingene HPV 28 Genotyping Detection Kit is ideal for:

• Cervical Cancer Screening: Identifies high-risk HPV infections to guide further diagnostic procedures like colposcopy.
• HPV Subtype Surveillance: Monitors the prevalence of specific HPV subtypes in populations, aiding in vaccine development and public health strategies.
• Follow-Up Testing: Assesses treatment efficacy in patients undergoing HPV-related therapies.
• Research Applications: Supports epidemiological studies on HPV transmission and oncogenic potential.

Image: Human Papilloma Virus HPV PCR

Company Background: Taizhou Cowingene Biotech Co., Ltd.

Taizhou Cowingene Biotech Co., Ltd. is a leading biotechnology company specializing in molecular diagnostics and infectious disease testing. With a commitment to innovation and quality, the company develops advanced solutions for healthcare providers worldwide. Their focus on PCR-based technologies ensures accurate, reliable, and cost-effective diagnostic tools for a wide range of applications.

As noted by the National Institute of Standards and Technology (NIST), "Standardized molecular diagnostic methods are critical for ensuring consistency and reliability in clinical testing. Technologies like PCR-based HPV detection play a pivotal role in advancing public health initiatives" [1]. Cowingene's adherence to rigorous validation protocols aligns with NIST's emphasis on precision and reproducibility in diagnostic workflows.

Conclusion

The Cowingene HPV 28 Genotyping Detection Kit is a cutting-edge solution for HPV detection, offering unparalleled accuracy and versatility. By leveraging advanced PCR technology, this kit empowers healthcare professionals to make informed decisions, ultimately improving patient outcomes and contributing to global cervical cancer prevention efforts.

References

[1] National Institute of Standards and Technology (NIST). (n.d.). Standards for Molecular Diagnostics. Retrieved from https://www.nist.gov/.